The Michael J. Fox Foundation (MJFF) has furthered its drive to establish wearable devices as part of the data-gathering toolkit in clinical trials of Parkinson's treatments. Cynapsus is collaborating with MJFF on the inclusion of a wearable-enabled sub-study in its Phase III trial. The alliance builds on a deal MJFF struck with Intel in 2014, which set out to improve the monitoring of Parkinson's patients between site visits through the use of wearable devices. Release